Navigation Links
MiddleBrook Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Financial Results on March 4, 2008
Date:2/29/2008

Conference Call and Webcast to Follow

GERMANTOWN, Md., Feb. 29 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced it will release results for the quarter and fiscal year ended December 31, 2007, on Tuesday, March 4, 2008, before the market opens. A full text copy of the release will be disseminated at that time.

Edward M. Rudnic, Ph.D., president and chief executive officer, will host a conference call to discuss the results and other corporate developments at 10:30 AM ET on Tuesday, March 4, 2008. Also participating on the call will be Robert C. Low, vice president, finance and CFO. To participate in the conference call, dial the appropriate number below shortly before the 10:30 AM start time and ask for the MiddleBrook Pharmaceuticals conference call hosted by Dr. Rudnic.

The teleconference dial-in numbers are as follows:

Domestic callers 1-800-813-8504

International callers 1-706-643-7752

The conference call will be broadcast simultaneously and archived on the Company's web site, http://www.middlebrookpharma.com. Investors should go to the web site at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Tuesday, March 4, 2008, beginning at 12:30 PM ET and will be accessible until Tuesday, March 11, 2008, at 5:00 PM ET. The replay call-in number is 1-800-642-1687 for domestic callers and 1-706-645-9291 for international callers. The access number is 375
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
2. MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
3. Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
4. BioCryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008
5. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
6. Memory Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Results on Thursday, March 6, 2008
7. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
8. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
9. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
10. Investor Alert from Cauley Bowman Carney & Williams, PLLC: Update on Proposed Acquisition of CollaGenex Pharmaceuticals, Inc. - CGPI
11. JSJ Pharmaceuticals Announces Launch of Aesthetic Division - Vitivia(TM)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...s Customers with Partners Validated to Process and...ts , Ottawa, ON (PRWEB) N...der of products for biological sample collection, ... new global partner program. The program offers si...ommunity and is designed to help partners scale an...
(Date:11/23/2009)...ovocative new study, a University of Utah scientis... major cause of global warming cannot be stabiliz... builds the equivalent of one new nuclear power pl...ill be any substantial near-term departure from re...ssion rates," says the new paper by Tim Garrett, a...
(Date:11/23/2009)...carbon layer in which the carbon atoms are arrange...Carbon nanotubes are rolled-up sheets of graphene,... Graphene boasts some very special characteristics...rmal conductor, and reconciles such conflicting qu... graphene is impermeable to gases, which makes it ...
(Date:11/23/2009)...irstCall/--NeogenCorporation(Nasdaq: NEOG )announc...en,sBoardofDirectorsatthecompany,srecentannualmeet...ofexperienceinthefood,agriculture,andtradeindustri...uraleconomicsatVirginiaTechUniversity.FromJanuary2...turenegotiatorwiththerankofambassador. ,, "Sinc...
Breaking Biology Technology:DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4Polymer with honeycomb structure 2Richard T. Crowder Joins Neogen's Board of Directors 2
..., Oct. 24 SenesTech, Inc. has initiated,field tri...sland of Java in,continuing research collaboration... Dr. Grant Singleton of the International Rice,Res...ta Mayer and Cheryl,Dyer of SenesTech, Inc. will j...cientific and Industrial Research Organisation (CS...
...t. 24 The Committee for,Medicinal Products for Hu...MEA) has adopted a negative opinion on a Cymbalta(...treatment of fibromyalgia., "Eli Lilly and Compan...ted by the CHMP,s opinion," said James Russell, M....lly and Company. "We remain,confident in the dulox...
...24 Favrille, Inc. (OTC,Bulletin Board: FVRL) anno... term sheet for a reverse merger whereby Favrille ...e company, MyMedicalRecords.com, Inc.,("MMR"), in ...becoming a,wholly-owned subsidiary of Favrille. If...rms set forth in the non-binding term sheet, at th...
Other Biology Technology:SenesTech, Inc. Initiates Research Field Trials for ContraPest(R) in Indonesia 2European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia 2European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia 3European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia 4European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia 5Favrille Announces Execution of Non-binding Term Sheet for a Merger Transaction 2
(Date:11/23/2009)...ire microbiologist Louis Tisa has received two gra...the actinorhizal plants, widespread woody plants w...ated soils. , The United States Department of A...ecular, cellular and biomedical sciences, $399,000... bacteria Frankia and Casuarina, an actinorhizal p...
(Date:11/23/2009)...edical engineer and cardiologist Tzung "John" Hsia...istinguish cardiac emergencies requiring immediate...gs and lifestyle change. , Angiograms, images ma... the heart, offer an inside view of the interior s...ealing deposits of a dangerous fatty substance cal...
(Date:11/23/2009)...sted for 360 million years and survived when the d...tening to make many of them extinct, according to ...Today . , The fungus, Batrachochytrium dendrob...s of amphibian extinctions in Central America and ...over 350 amphibian species by penetrating their sk...
Breaking Biology News(10 mins):UNH prof. receives nearly $500,000 to research environmentally significant plants 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Keryx Reports Results of Open Label Extension Study Examining Long Term Use of Zerenex an Iron Based Phosphate Binder for the Treatment of Hyperphos 5032 1Keryx Reports Results of Open Label Extension Study Examining Long Term Use of Zerenex an Iron Based Phosphate Binder for the Treatment of Hyperphos 5032 2Keryx Reports Results of Open Label Extension Study Examining Long Term Use of Zerenex an Iron Based Phosphate Binder for the Treatment of Hyperphos 5032 3Keryx Reports Results of Open Label Extension Study Examining Long Term Use of Zerenex an Iron Based Phosphate Binder for the Treatment of Hyperphos 5032 4Discovery could improve hepatitis C treatment 58129 1Discovery could improve hepatitis C treatment 58129 2InVitria Presents Zap CHO Performance Results at PEACe Conference 10054 1InVitria Presents Zap CHO Performance Results at PEACe Conference 10054 2
..., A collaboration between more than 70 researcher... the X chromosome that, when knocked-out, lead to ...ied almost all X chromosome genes in 208 families ... this type ever reported. , Remarkably, the team...omosome genes, when knocked-out, have no apparent ...
..., SALT LAKE CITY As the U.S. Southwest grew war... vanished from what is now the Mojave Desert, robb...ty of Utah biologists have narrowed the hunt for d... creosote bushes that replaced juniper. , "It wa...or Denise Dearing, senior author of the study, pub...
..., , As the U.S. Southwest grew warmer between 18,7...om what is now the Mojave Desert, robbing woodrats...rrowed the hunt for detoxification genes that let ...laced junipers. , "It was either eat it or move o...ty of Utah, lead author of a paper detailing the r...
Other Biology News:The genetic X-factor 2The genetic X-factor 3Poison: It's what's for dinner 2Poison: It's what's for dinner 3Poison: It's what's for dinner 4Poison: It's what's for dinner 5Desert woodrats switch one dietary poison for another 2
...y scanner based on patented confocal laser imaging...patial resolution. The DNAscope LM is unique beca...t is upgradeable to a total of 3 laser excitation ... (computer), monitor, and software easy to use ...
...ures an ultra-thin nitrocellulose coating for mult...rst protein microarray slide to provide the many b...background fluorescence providing excellent signal...ed for a variety of assays, such as sandwich immun...
Conjugate Stabilizing Diluent Alkaline Phosphatase from Meridian Life Science, Inc.
...Alkaline Phosphatase conjugates. The product insu...the enzyme and the antibody following long-term st...emically engineered to increase conjugate stabilit...stance to various shipping conditions and storage ...
Biology Products: